The Embedded Participant During High-fidelity Simulation

November 6, 2022 updated by: Lilot Marc, Claude Bernard University

The Role of the Embedded Participant on Learners' Performance During High- Fidelity Simulation

Simulation in medicine is a powerful and effective teaching tool that has become essential for the training of students and health professionals.

In this context, simulation instructor training have been implemented in recent years, where many subjects are addressed, such as the main principles of pedagogy, the integration of simulation, the construction of a scenario, briefing and debriefing.

However, scenario facilitation, in particular the role of the embedded participant (EP), is only vaguely discussed. The EP of a high-fidelity simulation session plays a very important role in driving the scenario. Indeed, he/she guides the learner in order to achieve all the educational objectives set by the main instructor of the scenario. He/she also manages unexpected behavior and possible technical issues that may arise. Finally, the EP supervises the physical and psychological risks inherent in the simulation in order to maintain a safe environment.

All of these key roles suggest that the EP can influence the performance of the learners. Little is known about the relationship between Facilitation and Learner Performance.

In this observational study, investigators aim to explore the influence of the embedded participant on learners' technical and non-technical performances during high-fidelity simulation by analysing previously recorded sessions.

Study Overview

Status

Completed

Conditions

Detailed Description

In this observational study, investigators aim to measure performance on high-fidelity simulation scenarios (HFS) used routinely in the current anesthesiology, training curriculum. Age, sex, previous experience of HFS will be noted. All data will be anonymized.

Two investigators will independently evaluate the performance of HFS by video record:

  • technical performance on tables pre-established by experienced instructors and based on international recommendations,
  • non-technical performances, assessed using the Ottawa Global Rating Scale.

Study Type

Observational

Enrollment (Actual)

340

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France
        • Claude Bernard University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Anaesthesia residents in postgraduate years 1-5 at Edouard Herriot Hospital, Lyon

Description

Inclusion Criteria:

  • Resident physicians in anesthesia/intensive care- postgraduate year 1-5 participating in HFS training sessions from 2015 to 2021
  • Consent for recording

Exclusion Criteria:

  • Denial to be recorded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Technical Skills Performance
Time Frame: 1 month (review video)
technical performance on a scale pre-established according to each scenario rated from 0 to 100.
1 month (review video)
Non-technical skills performance
Time Frame: 1 month (review video)
Ottawa Crisis Resource Management Global Rating Scale rated from 6 to 42.
1 month (review video)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographic characteristics
Time Frame: 1 month (collect data)
demographic data related to the instructors (embedded participants) through a questionary
1 month (collect data)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: thomas rimmele, PhD, Claude Bernard University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

October 30, 2022

Study Completion (Actual)

November 4, 2022

Study Registration Dates

First Submitted

May 10, 2021

First Submitted That Met QC Criteria

May 19, 2021

First Posted (Actual)

May 24, 2021

Study Record Updates

Last Update Posted (Actual)

November 8, 2022

Last Update Submitted That Met QC Criteria

November 6, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

3
Subscribe